We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
AI increases accuracy of bladder cancer diagnosis to 99%. Analysis of the VisioCyt vs Vesta battle: who received FDA breakthrough status and why it changes urology. Read.